Millennium Healthcare, Inc (MHCC) Financial Statements (2024 and earlier)
Company Profile
Business Address |
400 GARDEN CITY PLAZA GARDEN CITY, NY 11530 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 5047 - Medical, Dental, and Hospital Equipment and Supplies (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
12/31/2015 | 12/31/2014 | 12/31/2013 | |||
---|---|---|---|---|---|
ASSETS | |||||
Current Assets | |||||
Cash, cash equivalents, and short-term investments | 113 | 116 | |||
Cash and cash equivalents | 113 | 116 | |||
Receivables | 5,194 | 861 | |||
Inventory, net of allowances, customer advances and progress billings | 100 | 821 | |||
Inventory | 100 | 821 | |||
Prepaid expense | 617 | 427 | |||
Total current assets: | 6,024 | 2,225 | |||
Noncurrent Assets | |||||
Property, plant and equipment | 790 | 99 | |||
Intangible assets, net (including goodwill) | 55 | 82 | |||
Intangible assets, net (excluding goodwill) | 55 | 82 | |||
Other noncurrent assets | 430 | 82 | |||
Other undisclosed noncurrent assets | (55) | (82) | |||
Total noncurrent assets: | 1,220 | 181 | |||
TOTAL ASSETS: | 7,244 | 2,406 | |||
LIABILITIES AND EQUITY | |||||
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities, including: | 1,279 | 748 | |||
Other undisclosed accounts payable and accrued liabilities | 1,279 | 748 | |||
Debt | 2,863 | 2,228 | |||
Derivative instruments and hedges, liabilities | 1,061 | 1,878 | |||
Other undisclosed current liabilities | 3,744 | 1,811 | |||
Total current liabilities: | 8,947 | 6,665 | |||
Noncurrent Liabilities | |||||
Long-term debt and lease obligation | 350 | ||||
Long-term debt, excluding current maturities | 350 | ||||
Other undisclosed noncurrent liabilities | 338 | 338 | |||
Total noncurrent liabilities: | 688 | 338 | |||
Total liabilities: | 9,634 | 7,002 | |||
Equity | |||||
Equity, attributable to parent, including: | (2,390) | (4,596) | |||
Common stock | 13 | 6 | |||
Additional paid in capital | 77,428 | 47,936 | |||
Deferred compensation equity | (3,453) | (646) | |||
Accumulated deficit | (76,378) | (51,893) | |||
Warrants and rights outstanding | 200 | ||||
Other undisclosed equity, attributable to parent | 0 | (200) | |||
Total equity: | (2,390) | (4,596) | |||
TOTAL LIABILITIES AND EQUITY: | 7,244 | 2,406 |
Income Statement (P&L) ($ in thousands)
12/31/2015 | 12/31/2014 | 12/31/2013 | ||
---|---|---|---|---|
Revenues | 8,341 | 1,987 | ||
Gross profit: | 8,341 | 1,987 | ||
Operating expenses | (32,654) | (14,504) | ||
Operating loss: | (24,313) | (12,517) | ||
Nonoperating income (expense) | 45 | (373) | ||
Other nonoperating expense | (45) | (3,943) | ||
Interest and debt expense | (3,076) | (3,006) | ||
Loss from continuing operations before income taxes: | (27,344) | (15,896) | ||
Income tax benefit | 1,450 | |||
Loss from continuing operations: | (25,894) | (15,896) | ||
Loss before gain (loss) on sale of properties: | (25,894) | (15,896) | ||
Net loss: | (25,894) | (15,896) | ||
Other undisclosed net income (loss) attributable to parent | 1,536 | (682) | ||
Net loss attributable to parent: | (24,358) | (16,577) | ||
Preferred stock dividends and other adjustments | (128) | (117) | ||
Other undisclosed net income available to common stockholders, basic | 235 | |||
Net loss available to common stockholders, diluted: | (24,486) | (16,460) |
Comprehensive Income ($ in thousands)
12/31/2015 | 12/31/2014 | 12/31/2013 | ||
---|---|---|---|---|
Net loss: | (25,894) | (15,896) | ||
Comprehensive loss, net of tax, attributable to parent: | (25,894) | (15,896) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.